Diabetes pharm Flashcards
oral incretin mimetic
semaglutide
twice daily mimetics
exenatide
one daily mimetics
liraglutide, lixizenatide
once weekly mimetic
exenatide ER, Trulicity, ozempic
GLP-1 agonist MOA
enhances glucose dependent insulin secretion by the beta cells, suppresses glucagon secretion, slows gastric emptying, increases satiety
indication for incretin mimetics
monotherapy or adjunct therapy in patients taking metformin, SU, or TZD
3 day window for missed dose – glp agonist
exenatide ER, albigulutide, dulaglutide
5 day window for missed dose – glp agonist
5 day window for missed dose
rapid acting insulin types
insulin lispro, insulin aspart, insulin gluisine, inhaled human insulin
insulin lispro brand name
humalog
insulin lispro onset
15-30 minutes
insulin aspart brand name
novolog and fiasp
novolog onset
15-30 minutes
fiasp onset
5-20 minutes
insulin glulisine brand name
apidra
apidra onset
15-30 minutes
inhaled human insulin brand name
afrezza
afrezza onset
12-15 minutes
peak time for rapid-acting insulin
1-2 hours
duration for rapid acting insulin
3-5 hours
2.5-3 for afrezza
short acting insulin
regular insulin (U-100)
regular insulin brand name
Humulin R, Novolin R
onset for short acting
30-60 minutes